The latest research study “Separation Systems for Commercial Biotechnology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” by IMARC Group, finds that the global separation systems for commercial biotechnology market size reached US$ 25.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 36.1 Billion by 2028, exhibiting a growth rate (CAGR) of 5.94% during 2023-2028.

The separation systems for commercial biotechnology refer to solutions employed for separating and purifying biological products from complex mixtures and solutions, such as biochemicals, diagnostic reagents, and biopharmaceuticals. This process is based on the density, electrostatic charge, polarity, volatility, shape, diffusivity, and solubility of the product. It involves numerous equipment and devices, including biochips, membranes, chromatographs, centrifuges, filters, and microarrays. It also provides higher recovery, improved productivity, and minimized waste and water use during washing. As a result, separation systems are widely adopted in cosmetics, agriculture, food and beverage (FB), and pharmaceutical industries.

Separation Systems for Commercial Biotechnology Market Trends:

The market is primarily driven by the significant expansion in the pharmaceutical industry. In addition, the growing prevalence of chronic medical conditions is escalating the demand for cell-based therapies, biopharmaceuticals, and personalized drugs, which is contributing to the market demand for separation systems. Moreover, various technological advancements, including the development of innovative upstream bioprocessing technologies that stimulate the elimination of biohazardous by-products, represent another major growth-inducing factor.

Besides this, governments of numerous countries are helping small and medium-sized businesses (SMEs) to introduce new technologies, design, and implement high-tech strategies to enhance commercial capabilities across the world. Furthermore, the developing healthcare infrastructure and extensive research and development (RD) activities in biotechnology are also creating a favorable market outlook.

Request for a Free Sample Copy of This Report: https://www.imarcgroup.com/separation-systems-for-commercial-biotechnology-market/requestsample

Separation Systems for Commercial Biotechnology Market 2023-2028 Competitive Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Major Players Covered:

• Agilent Technologies Inc.
• Becton Dickinson and Company
• Repligen Corporation
• Sartorius AG
• Shimadzu Corporation
• Bio-Rad Laboratories Inc.
• Hitachi Ltd.
• Qiagen N.V
• Merck KGaA
• Pall Corporation (Danaher Corporation)
• PerkinElmer Inc.
• Thermo Fisher Scientific.

Key Market Segmentation:

The report has segmented the market on the basis of region, methods and application.

Breakup by Methods:

• Modern Methods

• • Microarray
  • Lab-on-a-Chip
  • Magnetic Separation
  • Others

• Conventional Methods

• • Chromatography
  • Flow Cytometry
  • Membrane Filtration
  • Others

Breakup by Application:

• Pharmaceutical

• • Vaccines
  • Proteins
  • Hormones and Insulin
  • Enzymes
  • Human Blood Plasma Fractionation
  • Mammalian Cell Cultures

• Food and Cosmetics
• Agriculture
• Others

Breakup by Region:

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC List of Figure:  https://www.imarcgroup.com/request?type=reportid=5734flag=C

Key highlights of the report:

• Market Performance (2017-2022)

• Market Outlook (2023-2028)

• Porter’s Five Forces Analysis

• Market Drivers and Success Factors

• SWOT Analysis

• Value Chain

• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact:

Company Name: IMARC Group
Contact Person: Elena Anderson
Email: [email protected]
Phone: +1-631-791-1145
Address: 134 N 4th St.
City: Brooklyn
State: NY
Country: United States